#genentech — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #genentech, aggregated by home.social.
-
https://www.europesays.com/ch/60767/ Roche breaks ground on US manufacturing facility #Genentech #investment #Manufacturing #MetabolicDiseases #Obesity #PharmaNews #Roche #tariffs
-
https://www.europesays.com/ch/58992/ Genentech fenebrutinib cuts relapsing MS relapses 51%-59% #BrainLesions #BTKInhibitor #fenebrutinib #Genentech #PhaseIIITrial #RelapseReduction #RelapsingMultipleSclerosis #RHHBY #Roche
-
https://www.europesays.com/ch/58053/ Genentech brings 45 ophthalmology abstracts to ARVO 2026 #abstracts #ARVO2026 #Genentech #ophthalmology #RetinalDisease #RHHBY #Roche #Susvimo #Vabysmo
-
https://www.europesays.com/ch/?p=55155 Genentech Launches All Eyes on DME Campaign #DamonWayans #diabetes #DiabeticMacularEdema #Genentech #ophthalmology #PatientAwarenessCampaign #RHHBY #Roche #VisionLoss
-
https://www.europesays.com/ch/51774/ Roche claims pharma’s largest GPU footprint at NVIDIA’s flagship GTC event #AIDrugDiscovery #BioHive2 #BlackwellGPU #EliLilly #Genentech #GTC2026 #LillyPod #NVIDIA #PharmaAIInfrastructure #RecursionPharmaceuticals #Roche
-
https://www.europesays.com/ch/45164/ Genentech persevERA breast cancer trial misses PFS goal #BreastCancer #FDAReview #Genentech #giredestrant #persevERA #PhaseIII #ProgressionFreeSurvival #RHHBY #Roche
-
https://www.europesays.com/ch/31459/ Genentech fenebrutinib slashes MS relapses 51% #BTKInhibitor #fenebrutinib #Genentech #MultipleSclerosis #PhaseIII #PrimaryProgressiveMS #RelapseRate #RelapsingMS #RHHBY #Roche #teriflunomide
-
https://www.europesays.com/ch/30458/ Genentech petrelintide sheds 10.7% weight in Phase II #ClinicalTrial #Genentech #Obesity #overweight #petrelintide #PhaseII #RHHBY #Roche #WeightLoss
-
https://www.europesays.com/ch/27264/ FDA pushes back decision on Sanofi’s BTK inhibitor; Roche makes a deal with Starpharma #Genentech #Ipsen #LiverFailure #MultipleSclerosis #NewsBriefing #Obesity #Roche #Sanofi #SciwindBiosciences #Starpharma #tolebrutinib
-
https://www.europesays.com/ch/26890/ Biopharma giant Roche pledges new factory in Holly Springs #Genentech #HollySprings #jobs #nc #Roche #WakeCounty
-
https://www.europesays.com/ch/26867/ Roche’s obesity drug shows up to 10.7% weight loss in mid-stage trial #BodyWeight #DevelopmentRights #Genentech #Roche #ZealandPharma
-
Health organizations attacking Trump's Tylenol-autism claims are cozied up with Big Pharma
-
Health organizations attacking Trump's Tylenol-autism claims are cozied up with Big Pharma
-
🔍 Explore Advanced Data Visualization Techniques!
👨💻 Presented by Daniel Sjoberg, Software Engineer at Genentech, our latest webinar on "Visualizing Survival Data with the ggsurvfit R Package" is now available. Perfect for those who love digging deep into data with R!
🎥 Stream it here: https://www.r-consortium.org/r-medicine-webinar-visualizing-survival-data-with-the-ggsurvfit-r-package
-
🔍 Explore Advanced Data Visualization Techniques!
👨💻 Presented by Daniel Sjoberg, Software Engineer at Genentech, our latest webinar on "Visualizing Survival Data with the ggsurvfit R Package" is now available. Perfect for those who love digging deep into data with R!
🎥 Stream it here: https://www.r-consortium.org/r-medicine-webinar-visualizing-survival-data-with-the-ggsurvfit-r-package
-
🔍 Explore Advanced Data Visualization Techniques!
👨💻 Presented by Daniel Sjoberg, Software Engineer at Genentech, our latest webinar on "Visualizing Survival Data with the ggsurvfit R Package" is now available. Perfect for those who love digging deep into data with R!
🎥 Stream it here: https://www.r-consortium.org/r-medicine-webinar-visualizing-survival-data-with-the-ggsurvfit-r-package
-
🔍 Explore Advanced Data Visualization Techniques!
👨💻 Presented by Daniel Sjoberg, Software Engineer at Genentech, our latest webinar on "Visualizing Survival Data with the ggsurvfit R Package" is now available. Perfect for those who love digging deep into data with R!
🎥 Stream it here: https://www.r-consortium.org/r-medicine-webinar-visualizing-survival-data-with-the-ggsurvfit-r-package
-
🔍 Explore Advanced Data Visualization Techniques!
👨💻 Presented by Daniel Sjoberg, Software Engineer at Genentech, our latest webinar on "Visualizing Survival Data with the ggsurvfit R Package" is now available. Perfect for those who love digging deep into data with R!
🎥 Stream it here: https://www.r-consortium.org/r-medicine-webinar-visualizing-survival-data-with-the-ggsurvfit-r-package
-
FTC scrutiny chills medtech M&A market — Pfizer inks manufacturing deals with Samsung Biologics worth nearly $900M -- Genentech starting to adopt menopause benefits as they work on recruiting and retaining female employees -- See more on our front page news http://bit.ly/w28kSd #ftc #medtech #mergersandacquistions #antitrust #pfizer #samsung #drugmanufacturing #genentech #menopause #employees #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
FTC scrutiny chills medtech M&A market — Pfizer inks manufacturing deals with Samsung Biologics worth nearly $900M -- Genentech starting to adopt menopause benefits as they work on recruiting and retaining female employees -- See more on our front page news http://bit.ly/w28kSd #ftc #medtech #mergersandacquistions #antitrust #pfizer #samsung #drugmanufacturing #genentech #menopause #employees #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
"In 2009, Marc Tessier-Lavigne, then a top executive at the biotechnology company #Genentech, was the primary author of a #scientific paper published in the prestigious journal Nature that claimed to have found the potential cause for brain degeneration in #Alzheimer’s patients.
[…] Neither a correction nor a retraction was issued, and the paper stands to this day."Impressive investigation by #TheoBaker: https://stanforddaily.com/2023/02/17/internal-review-found-falsified-data-in-stanford-presidents-alzheimers-research-colleagues-allege/ #medicines #authorship #science #historyOfScience #ethics 🧶
-
My latest clinical pipeline column for @NatureMedicine is out today.
It's a look at the recent approval of mosunetuzumab, #Genentech's bispecific anti CD20/CD3 monoclonal antibody
for relapsed or refractory follicular #lymphoma.#FollicularLymphoma #Hematology #MonoclonalAntibody #DrugDevelopment
-
My latest clinical pipeline column for @NatureMedicine is out today.
It's a look at the recent approval of mosunetuzumab, #Genentech's bispecific anti CD20/CD3 monoclonal antibody
for relapsed or refractory follicular #lymphoma.#FollicularLymphoma #Hematology #MonoclonalAntibody #DrugDevelopment
-
My latest clinical pipeline column for @NatureMedicine is out today.
It's a look at the recent approval of mosunetuzumab, #Genentech's bispecific anti CD20/CD3 monoclonal antibody
for relapsed or refractory follicular #lymphoma.#FollicularLymphoma #Hematology #MonoclonalAntibody #DrugDevelopment
-
My latest clinical pipeline column for @NatureMedicine is out today.
It's a look at the recent approval of mosunetuzumab, #Genentech's bispecific anti CD20/CD3 monoclonal antibody
for relapsed or refractory follicular #lymphoma.#FollicularLymphoma #Hematology #MonoclonalAntibody #DrugDevelopment
-
#COVID NEWS (USA)
#FDA approved a new indication for the #monoclonal #antibody tocilizumab (Actemra, #Genentech) for treatment of hospitalized adults with #COVID19 receiving systemic corticosteroids and requiring supplement oxygen, mechanical ventilation (invasive or non-invasive), or #ECMO.
-
Only 2% of genomic material available for research comes from Africa, 54gene wants to change that - New advances in genetic mapping and manipulation hold the promise of reshaping medical treatments in... more: http://feedproxy.google.com/~r/Techcrunch/~3/738PB-Bb2hg/ #chiefoperatingofficer #universityoftexas #betterventures #pharmaceutical #sanfrancisco #ycombinator #california #eastafrica #genentech #diabetes #illumina #nigeria #africa #cancer #lagos #roche #texas #tc